Do you want to read an article? Please log in or register.
SANTORINI: Gender inequalities in cardiovascular disease treatment and goal attainment
Cardiovascular Risk and Diseases
ESC 2024
Related content
Heart, Artery and Coronary Diseases
Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Eur Heart J
Mazhar F, Faucon AL, Fu EL, Szummer KE, Mathisen J, Gerward S, Reuter SB, Marx N, Mehran R, Carrero JJ
doi: 10.1093/eurheartj/ehae557
Further Publications
Non-malignant gynaecological disease and risk of cardiovascular or cerebrovascular disease: a systematic review and meta-analysis
Heart
Colombo GE, Mahamat-Saleh Y, Armour M, Madan K, Sabag A, Kvaskoff M, Missmer SA, Condous G, Pathan F, Leonardi M
doi: 10.1136/heartjnl-2024-324675
Cardiovascular Risk and Diseases
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
Eur Heart J
Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith AB, Dwight J, Ruciński M, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guðmundsdóttir IJ, Hrafnkelsdóttir ÞJ, Ingimarsdóttir IJ, Irs A, Jánosi A, Járai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP, Global Cardiovascular Outcomes Consortium and in collaboration with ACNAP, ACVC, EACVI, EAPC, EAPCI, EHRA, ESC Committee for Young CV Professionals, ESC Registry Committee, HFA, ESC Patient Forum and these Working Groups: aorta and peripheral vascular diseases, atherosclerosis and vascular biology, cardiac cellular electrophysiology, cardiovascular pharmacotherapy, cardiovascular regenerative and restorative medicine, cardiovascular surgery, cellular biology of the heart, e-cardiology, myocardial function, pulmonary circulation and right ventricular function and thrombosis
doi: 10.1093/eurheartj/ehae724
RECOMMENDED
Cardiovascular Risk and DiseasesFurther Publications
Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Klug EQ, Llerena S, Burgess LJ, Fourie N, Scott R, Vest J, Caldwell K, Kallend D, Stein EA, LIBERATE-HR Investigators
doi: 10.1001/jamacardio.2024.1659
Cardiovascular Risk and Diseases
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality
JAMA Cardiol
Giao DM, Col H, Larbi Kwapong F, Turkson-Ocran RA, Ngo LH, Cluett JL, Wagenknecht L, Windham BG, Selvin E, Lutsey PL, Juraschek SP
doi: 10.1001/jamacardio.2024.5213
Further Publications
Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
JAMA Cardiol
Kohli-Lynch CN, Moran AE, Kazi DS, Bibbins-Domingo K, Jordan N, French D, Zhang Y, Wang TJ, Bellows BK
doi: 10.1001/jamacardio.2024.4812
Heart, Artery and Coronary Diseases
Hospitalized upper extremity artery disease patients: treatment and long-term outcomes
Eur Heart J
Makowski L, Engelbertz C, Köppe J, Dröge P, Ruhnke T, Günster C, Gerß J, Freisinger E, Malyar N, Reinecke H, Feld J
doi: 10.1093/eurheartj/ehae904
Cardiovascular Risk and Diseases
The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
Mayo Clin Proc
Köhler TS, Kloner RA, Rosen RC, Burnett AL, Blaha MJ, Ganz P, Goldstein I, Kim NN, Lue T, McVary KT, Mulhall JP, Parish SJ, Sadeghi-Nejad H, Sadovsky R, Sharlip ID, Miner M
doi: 10.1016/j.mayocp.2024.06.002
Cardiovascular Risk and DiseasesFurther Publications
Exploring the Link Between Genetic Predictors of Cardiovascular Disease and Psoriasis
JAMA Cardiol
Ramessur R, Saklatvala J, Budu-Aggrey A, Ostaszewski M, Möbus L, Greco D, Ndlovu M, Mahil SK, Barker JN, Brown S, Paternoster L, Dand N, Simpson MA, Smith CH
doi: 10.1001/jamacardio.2024.2859